Moderna financials
$203.46+3.13%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.94B | $3.24B | $6.85B | $19.26B | $18.47B | $803.0M | $60.0M | $135.1M |
| Gross profit | $1.08B | $1.77B | $2.15B | $13.85B | $15.85B | $795.0M | $60.0M | $135.1M |
| Gross margin | 55.3% | 54.8% | 31.5% | 71.9% | 85.8% | 99.0% | 100.0% | 100.0% |
| Operating income | -$3.07B | -$3.94B | -$4.24B | $9.42B | $13.30B | -$763.0M | -$546.0M | -$413.3M |
| Net income | -$2.82B | -$3.56B | -$4.71B | $8.36B | $12.20B | -$747.0M | -$514.0M | -$401.9M |
| Net margin | −145.2% | −110.0% | −68.8% | 43.4% | 66.1% | −93.0% | −856.7% | −297.5% |
| Diluted EPS | $-7.26 | $-9.28 | $-12.33 | $20.12 | $28.29 | $-1.96 | $-1.55 | $-4.95 |
| EBITDA | -$2.86B | -$3.76B | -$3.62B | $9.77B | $13.53B | -$732.0M | -$515.0M | -$388.4M |
| Operating cash flow | -$1.87B | -$3.00B | -$3.12B | $4.98B | $13.62B | $2.03B | -$459.0M | -$330.9M |
| Free cash flow | -$2.06B | -$4.05B | -$3.83B | $4.58B | $13.34B | $1.96B | -$491.0M | -$436.6M |
| Diluted shares | 389.0M | 384.0M | 382.0M | 416.0M | 431.0M | 381.0M | 331.0M | 81.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.60B | $1.93B | $2.91B | $3.21B | $6.85B | $2.62B |
| Short-term investments | $3.20B | $5.10B | $5.70B | $6.70B | $3.88B | $1.98B |
| Total debt | $610.0M | $39.0M | $575.0M | $912.0M | $599.0M | $110.0M |
| Total assets | $12.34B | $14.14B | $18.43B | $25.86B | $24.67B | $7.34B |
| Total liabilities | $3.69B | $3.24B | $4.57B | $6.74B | $10.52B | $4.78B |
| Shareholders' equity | $8.65B | $10.90B | $13.85B | $19.12B | $14.14B | $2.56B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology